Dilemma and Challenge of Immunotherapy for Pancreatic Cancer.

Digestive Diseases and Sciences
Jia Wu, Jianting Cai

Abstract

Pancreatic cancer is a tumor with a high degree of malignancy, morbidity, and mortality. Immunotherapy is another important treatment for pancreatic cancer in addition to surgery and chemotherapy, but its application in pancreatic cancer is very limited, which is related to the unique biological behavior of pancreatic cancer and the tumor microenvironment. The immunosuppressive microenvironment of pancreatic cancer is highly heterogeneous and presents challenges for immunotherapy. The transformation of tumor immunosuppressive microenvironment contributes to the response to tumor immunotherapy, such that the tumor undergoes functional reprogramming to change from immunologically "cold" to immunologically "hot." In this review, we summarized the research and progress in immunotherapy for pancreatic cancer, including immune checkpoint inhibitors, vaccines, adoptive T cell therapy, oncolytic viruses, and immunomodulators, and suggest that individualized, combination, and precise therapy should be the main direction of future immunotherapy in pancreatic cancer.

References

Oct 23, 2010·Gut·Albrecht NeesseDavid A Tuveson
Sep 20, 2012·Journal of Surgical Oncology·Elan R WitkowskiJennifer F Tseng
Oct 15, 2013·The Journal of Pathology·Jérôme GalonFranck Pagès
Apr 26, 2014·Cancer Immunology Research·E Antonio Chiocca, Samuel D Rabkin
Jul 6, 2014·Nature Reviews. Cancer·Brian D LichtyJohn C Bell
Jan 15, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dung T LeElizabeth M Jaffee
Jul 29, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Xuewen LiuAlain C Borczuk
Jan 21, 2016·Immunotherapy·Andrew L CovelerE Gabriela Chiorean
Feb 3, 2016·Lancet·Terumi KamisawaKyoichi Takaori
Feb 26, 2016·Nature·Peter BaileySean M Grimmond
Mar 12, 2016·Cancer Research·Henrique LemosAndrew L Mellor
Apr 5, 2016·Molecular Therapy : the Journal of the American Society of Gene Therapy·Anne M NoonanTanios S Bekaii-Saab
May 22, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J M Kim, D S Chen
Nov 20, 2016·Gastroenterology·Jeremy L HumphrisAndrew V Biankin
Dec 23, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David BalliRobert H Vonderheide
Feb 6, 2017·Cancer Research·Xianda Zhao, Subbaya Subramanian
Mar 28, 2017·Journal of Surgical Oncology·Carl J DeSelmPrasad S Adusumilli
Mar 30, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Erik S KnudsenAgnieszka K Witkiewicz
Apr 14, 2017·Journal of Surgical Oncology·Ahmad Rahal, Benjamin Musher
May 26, 2017·Nature·Michel SadelainStanley Riddell
Jun 10, 2017·Immunotherapy·Francesca Aroldi, Alberto Zaniboni
Jul 12, 2017·Cancer Cell International·Qiaofei LiuYupei Zhao
Aug 9, 2017·Journal of the National Comprehensive Cancer Network : JNCCN·Margaret A TemperoSusan Darlow
Aug 23, 2017·Cancer Letters·Mengyu FengYupei Zhao
Sep 20, 2017·Journal of the National Cancer Institute·Laetitia MarisaAlex Duval
Oct 11, 2017·Cellular and Molecular Life Sciences : CMLS·Chen LiangXianjun Yu
Dec 13, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sunil R HingoraniAndrew E Hendifar
Dec 16, 2017·Cancer Letters·Kasturi BanerjeeManeesh Jain
Dec 31, 2017·Gastroenterology·Claire VenninPaul Timpson
Jan 10, 2018·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Mar 20, 2018·Current Opinion in Immunology·Nan ChenPrasad S Adusumilli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Journal of Cancer Research and Clinical Oncology
Elias KotteasKonstantinos Syrigos
Molecular Biology Reports
Ilgin Kimiz-GebologluCigir Biray-Avci
Expert Opinion on Biological Therapy
Fang Liu, Muhammad Wasif Saif
Sheng wu gong cheng xue bao = Chinese journal of biotechnology
Zongyi ShenZhao Yang
© 2021 Meta ULC. All rights reserved